← Back to Clinical Trials
Recruiting NCT06023225

NCT06023225 Sex Hormones, Postoperative Pain and Opioid Use

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06023225
Status Recruiting
Phase
Sponsor Washington University School of Medicine
Condition Postoperative Pain
Study Type OBSERVATIONAL
Enrollment 210 participants
Start Date 2023-09-01
Primary Completion 2027-07-01

Eligibility & Interventions

Sex Female only
Min Age 11 Years
Max Age 16 Years
Study Type OBSERVATIONAL
Interventions
PainOpioid use

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 210 participants in total. It began in 2023-09-01 with a primary completion date of 2027-07-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Aim 1- To identify relationships between sex hormone levels and postoperative pain and opioid use. Aim 2: To determine whether the effects of testosterone on postoperative pain and opioid use are mediated by immune factors

Eligibility Criteria

Inclusion Criteria: Pediatric female patients between the ages 11-16 undergoing an orthopedic (trauma and non-trauma) surgical procedure involving a long bone or joint, or the spine, English speaking Exclusion Criteria: Pregnancy; Diagnosis of chronic pain, Psychiatric, developmental or neurological disorders, Disorders that are associated with pubertal maturation (e.g., precocious puberty).

Frequently Asked Questions

Who can join the NCT06023225 clinical trial?

This trial is open to female participants only, aged 11 Years or older, up to 16 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06023225 currently recruiting?

Yes, NCT06023225 is actively recruiting participants. Visit ClinicalTrials.gov or contact Washington University School of Medicine to inquire about joining.

Where is the NCT06023225 trial being conducted?

This trial is being conducted at St Louis, United States.

Who is sponsoring the NCT06023225 clinical trial?

NCT06023225 is sponsored by Washington University School of Medicine. The trial plans to enroll 210 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology